Position in TERN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,470,057
-56.5% QoQ
Ownership
1.27%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
4 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in TERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $15,213,180,190 across 182 Biotechnology names. TERN ranks #174 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,541,732 | $1,856,099,791 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
3,458,863 | $1,114,411,067 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,018,647 | $1,056,701,142 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
13,179,013 | $978,673,503 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
16,575,875 | $963,224,094 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,131,527 | $951,812,064 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
9,766,496 | $949,791,733 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
6,945,813 | $641,654,204 |
All Filings in TERN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 1,470,057 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | — | 3,379,569 | Shares | Defined | 2026-02-17 | |
| 2024-03-31 | — | 2,003,263 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | — | 1,424,763 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||